Dr. Menefee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
CA-60
Cleveland, OH 44195Phone+1 216-445-7920Fax+1 216-444-9464
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2002 - 2006
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1999 - 2002
- Meharry Medical CollegeClass of 1999
Certifications & Licensure
- MD State Medical License 2004 - 2025
- OH State Medical License 2023 - 2025
- DC State Medical License 2002 - 2024
- FL State Medical License 2000 - 2022
- GA State Medical License 2014 - 2017
- MN State Medical License 2006 - 2007
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery Start of enrollment: 2009 Feb 01
- Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer Start of enrollment: 2009 Nov 03
- Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer Start of enrollment: 2010 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsA phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma.Hao Xie, Jun Yin, Manisha H. Shah, Michael E. Menefee, Keith C. Bible
Investigational New Drugs. 2019-01-01 - 10 citationsFoundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy.Nicole M. Iñiguez-Ariza, Sina Jasim, Mabel Ryder, Ashish V. Chintakuntlawar, John C. Morris
The Journal of Clinical Endocrinology and Metabolism. 2020-07-01 - 85 citationsCabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International T...Maria E. Cabanillas, Jonas A. De Souza, Susan Geyer, Lori J. Wirth, Michael E. Menefee
Journal of Clinical Oncology. 2017-08-17
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: